A pilot study of neoadjuvant combination of anti-PD-1 camrelizumab and VEGFR2 inhibitor apatinib for locally advanced resectable oral squamous cell carcinomaWu‐tong Ju, Lai‐ping Zhong|Nature Communications|2022Cited by 119
Overcoming chemotherapy resistance using pH-sensitive hollow MnO2 nanoshells that target the hypoxic tumor microenvironment of metastasized oral squamous cell carcinomaZhi-Hang Zhou, Lai‐ping Zhong|Journal of Nanobiotechnology|2021Cited by 56
Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinomaHailong Ma, Lai‐ping Zhong|Journal of Experimental & Clinical Cancer Research|2017Cited by 35